PURPOSE: Platelet-rich plasma (PRP) contains growth factors and creates a 3D structure upon clotting; PRP or platelet lysate (PL) might be considered for annulus fibrosus (AF) repair. METHODS: Bovine AF cells were cultured with 25% PRP, 50% PRP, 25% PL, 50% PL, or 10% FBS. After 2 and 4 days, DNA, glycosaminoglycan (GAG), and mRNA levels were analyzed. Histology was performed after injection of PRP into an AF defect in a whole disc ex vivo. RESULTS: By day 4, significant increases in DNA content were observed in all treatment groups. All groups also showed elevated GAG synthesis, with highest amounts at 50% PL. Collagen I and II expression was similar between groups; aggrecan, decorin, and versican expression was highest at 25% PL. Injection of PRP into the AF defect resulted in an increased matrix synthesis. CONCLUSIONS: Platelet-rich preparations increased the matrix production and cell number and may therefore be considered to promote AF repair.
PURPOSE: Platelet-rich plasma (PRP) contains growth factors and creates a 3D structure upon clotting; PRP or platelet lysate (PL) might be considered for annulus fibrosus (AF) repair. METHODS:BovineAF cells were cultured with 25% PRP, 50% PRP, 25% PL, 50% PL, or 10% FBS. After 2 and 4 days, DNA, glycosaminoglycan (GAG), and mRNA levels were analyzed. Histology was performed after injection of PRP into an AF defect in a whole disc ex vivo. RESULTS: By day 4, significant increases in DNA content were observed in all treatment groups. All groups also showed elevated GAG synthesis, with highest amounts at 50% PL. Collagen I and II expression was similar between groups; aggrecan, decorin, and versican expression was highest at 25% PL. Injection of PRP into the AF defect resulted in an increased matrix synthesis. CONCLUSIONS: Platelet-rich preparations increased the matrix production and cell number and may therefore be considered to promote AF repair.
Authors: Caroline Rauch; Elisabeth Feifel; Eva-Maria Amann; Hans Peter Spötl; Harald Schennach; Walter Pfaller; Gerhard Gstraunthaler Journal: ALTEX Date: 2011 Impact factor: 6.043
Authors: Mario Cabraja; Michaela Endres; Aldemar A Hegewald; Samuel Vetterlein; Claudius Thomé; Christian Woiciechowsky; Christian Kaps Journal: J Neurosurg Spine Date: 2012-05-25
Authors: Sebastian Lippross; Markus Loibl; Sven Hoppe; Thomas Meury; Lorin Benneker; Mauro Alini; Sophie Verrier Journal: Platelets Date: 2011-04-07 Impact factor: 3.862
Authors: C C Guterl; E Y See; S B G Blanquer; A Pandit; S J Ferguson; L M Benneker; D W Grijpma; D Sakai; D Eglin; M Alini; J C Iatridis; S Grad Journal: Eur Cell Mater Date: 2013-01-02 Impact factor: 3.942
Authors: F Duttenhoefer; R Lara de Freitas; T Meury; M Loibl; L M Benneker; R G Richards; M Alini; S Verrier Journal: Eur Cell Mater Date: 2013-08-29 Impact factor: 3.942
Authors: Aldemar A Hegewald; Sabra Zouhair; Michaela Endres; Mario Cabraja; Christian Woiciechowsky; Claudius Thomé; Christian Kaps Journal: Tissue Cell Date: 2012-11-01 Impact factor: 2.466
Authors: Stefan Stich; Anke Möller; Mario Cabraja; Jan Philipp Krüger; Sylvia Hondke; Michaela Endres; Jochen Ringe; Michael Sittinger Journal: Int J Mol Sci Date: 2018-07-28 Impact factor: 5.923
Authors: Michael Wolff; Jon Mark Shillington; Christopher Rathbone; Shawn K Piasecki; Brian Barnes Journal: BMC Musculoskelet Disord Date: 2020-02-28 Impact factor: 2.362